Laboratory measures of exercise capacity and ventricular characteristics and function are weakly associated with

Brian W McCrindle1, Victor Zak, Lynn A Sleeper

  • 1Hospital for Sick Children, 555 University Ave, Toronto, Ontario, Canada M5G 1X8. brian.mccrindle@sickkids.ca

Circulation
|December 23, 2009
PubMed

Insights

Functional health status in Fontan procedure patients is not strongly predicted by common laboratory measures. These findings suggest laboratory values may not be ideal surrogate endpoints for clinical trials in this population.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Fontan Procedure Outcomes

Background:

  • Patients undergoing the Fontan procedure face risks of diminished functional health.
  • Understanding associations between laboratory measures and health status is crucial for interventions and clinical trial outcomes.

Purpose of the Study:

  • To investigate the relationship between functional health status and various laboratory and imaging measures in Fontan procedure survivors.
  • To determine if laboratory measures can serve as effective surrogate endpoints in clinical trials.

Main Methods:

  • Utilized the Child Health Questionnaire (CHQ) to assess functional health status in 511 Fontan patients (aged 6-18).
  • Performed regression analyses to correlate CHQ Physical and Psychosocial Functioning Summary Scores (FSS) with exercise testing, echocardiography, MRI, and brain natriuretic peptide levels.

Main Results:

  • Higher Physical FSS was weakly associated with higher maximum work rate on exercise tests (9% variation).
  • Echocardiographic factors (lower Tei index, lower end-systolic volume, absence of AV regurgitation) and MRI findings (lower mass to end-diastolic volume ratio) correlated with better Physical FSS (14% and 11% variation, respectively).
  • Brain natriuretic peptide showed a weak association with Physical FSS (1% variation); psychosocial functioning had fewer and weaker associations with laboratory measures.

Conclusions:

  • Laboratory measures explain only a small portion of the variation in functional health status among relatively healthy Fontan patients.
  • Current laboratory measures may not be optimal surrogate endpoints for evaluating therapeutic interventions in Fontan survivors.
Abstract